BridgeMD
New treatment option for Primary Dysmenorrhea
Official title Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea
ClinicalTrials.gov ID: NCT06777940
What this study is testing
- What it's testing
- The rationale of this study is despite the widespread belief that exercise can reduce dysmenorrhea, evidence-based studies are limited. Studies are therefore required to evaluate the association between quality of life and the primary dysmenorrheal females, the functional impact on the quality of life and primary dysmenorrhea females also it's a crucial time for females to focus on their studies and dysmenorrhea can add to the fatigue levels and cause distress in this age group thus the purpose of this study is to determine whether myokinetic active release of trigger points in the rectus abdominis, gluteus medius and quadratus lumborum is a more effective way to reduce dysmenorrhea than kegel exercises
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 17 to 25, women only
You may be able to join if
- Age 17-25 years
- Diagnosed cases of dysmenorrhea
- Subject having trigger point in rectus abdominins, quadratus lumborum and gluteus medius
- With regular cycles 21-35 days lasting 3-7 days
You likely can't join if
- Oral contraceptives used for menstrual irregularity
- Other gynecological disease like fibroids, endometriosis
- Who take analgesia
- Endometrial polyp, having pelvic infection using IUD, having venous congestion in internal genital organs.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 17 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.